Tracing Ascent Capital’s returns from partial exit in drug ingredients maker

Premium

Homegrown private equity firm Ascent Capital appears to have scored neat returns from a partial exit in one of India’s topmost pharmaceutical ingredient makers in which it had invested through a fund of 2009 vintage. Ascent Capital has sold more than half its stake in Mumbai-listed Solara Active Pharma Sciences Ltd, ......